Vanguard Group Inc Cerevel Therapeutics Holdings, Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,463,911 shares of CERE stock, worth $305 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,463,911
Previous 7,374,970 1.21%
Holding current value
$305 Million
Previous $313 Million 0.9%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$40.88 - $43.27 $3.64 Million - $3.85 Million
88,941 Added 1.21%
7,463,911 $315 Million
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $20.3 Million - $42.6 Million
1,003,594 Added 15.75%
7,374,970 $313 Million
Q3 2023

Nov 14, 2023
BUY
$20.26 - $31.91 $14.4 Million - $22.6 Million
708,826 Added 12.52%
6,371,376 $139 Million
Q2 2023

Aug 14, 2023
SELL
$23.9 - $35.38 $11.1 Million - $16.4 Million
-464,030 Reduced 7.57%
5,662,550 $180 Million
Q1 2023

May 15, 2023
BUY
$22.82 - $35.32 $2.01 Million - $3.11 Million
88,119 Added 1.46%
6,126,580 $149 Million
Q4 2022

Feb 10, 2023
BUY
$25.35 - $31.96 $4.17 Million - $5.26 Million
164,460 Added 2.8%
6,038,461 $190 Million
Q3 2022

Nov 14, 2022
BUY
$25.5 - $41.42 $22 Million - $35.7 Million
861,581 Added 17.19%
5,874,001 $166 Million
Q2 2022

Aug 12, 2022
BUY
$20.62 - $37.15 $4.18 Million - $7.53 Million
202,727 Added 4.21%
5,012,420 $133 Million
Q1 2022

May 13, 2022
BUY
$23.5 - $35.38 $184,616 - $277,945
7,856 Added 0.16%
4,809,693 $168 Million
Q4 2021

Feb 14, 2022
BUY
$29.21 - $44.64 $3.17 Million - $4.85 Million
108,678 Added 2.32%
4,801,837 $156 Million
Q3 2021

Nov 12, 2021
BUY
$21.26 - $38.85 $24.8 Million - $45.4 Million
1,168,443 Added 33.15%
4,693,159 $138 Million
Q2 2021

Aug 13, 2021
BUY
$12.56 - $29.69 $44.3 Million - $105 Million
3,524,716 New
3,524,716 $90.3 Million

Others Institutions Holding CERE

# of Institutions
227
Shares Held
150M
Call Options Held
939K
Put Options Held
961K
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Market Cap $6.37B
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email